AMG 827 in Subjects With Moderate to Severe Crohn's Disease
Status:
Terminated
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The study will examine the safety and effectiveness of AMG 827 for the treatment of moderate
to severe Crohn's disease. Patients will randomly receive either AMG 827 or placebo (a
lookalike liquid that doesn't have any drug in it) and neither the doctor nor the patient
will know what treatment is being given.